The increased SAM content and DNA methylation with upregulated DNA methyltransferases suggest metabolic reprogramming coupled with epigenetic alterations contribute to oncogenic effects of LKB1 deficiency in KRAS mutant pancreatic cancer cells. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.